In this episode of the Digital Health Transformers podcast, Meghna Misra, Head of Product at ClaritasRx, discusses how AI is transforming patient visibility across specialty, rare disease, oncology, and CAR T therapies. She explains how predictive analytics enable care teams to identify risks such as prior authorization denials, refill delays, and therapy drop-offs before they occur. Meghna emphasizes that the real value of AI lies not only in prediction but in turning insights into clear actions embedded within existing workflows.

The conversation explores the importance of transparency, explainability, and trust in high-stakes healthcare use cases. Meghna shares real-world outcomes from ClaritasRx, including measurable improvements in fill and refill rates driven by AI-powered risk models. She also discusses the role of healthcare leaders ...